EndoBytes: Patient-Centered Approach to Hypercortisolism Screening and Care
Availability
On-Demand
Release on Dec 16, 2025 9:00 PM Central Standard Time
Expires on Dec 31, 2026
Cost
$0.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures

Hypercortisolism is a complex, multisystemic, and often recurrent condition resulting from prolonged exposure of tissues to cortisol and related glucocorticoids. Because it manifests through a wide range of symptoms, many of which overlap with highly prevalent comorbidities, such as hypertension, diabetes, and obesity, patients frequently experience delays in recognition and diagnosis.

To address these persistent clinical challenges, this EndoBytes educational series is designed to enhance clinicians’ understanding of hypercortisolism as a multifaceted disease. The program will explore key issues in screening and diagnosing at-risk individuals, highlight recent advancements in hypercortisolism pharmacotherapy, and provide guidance on individualized treatment and long-term management. Through concise, targeted learning segments, participants will gain practical strategies to improve clinical decision-making and patient outcomes in hypercortisolism care.

The target audience for this program includes endocrinologists, primary care providers, endocrinology PAs, and endocrinology nurses treating patients with or at risk for hypercortisolism.
1. Examine the physiological causes and metabolic effects of hypercortisolism, highlighting the systemic impact of cortisol on the cardiovascular, neurological, musculoskeletal, and immune systems

2. Enhance understanding of how pathological excess glucocorticoid receptor activity impacts patient health 

3. Evaluate the broad spectrum of clinical presentation for hypercortisolism and more confidently identify patients warranting initial screening 

4. Develop an individualized, patient-centered treatment plans for monitoring hypercortisolism symptoms

5. Foster interdisciplinary collaboration among academic researchers and clinicians, with an emphasis on addressing healthcare disparities to ensure equitable access to hypercortisolism screening, diagnosis, treatment, and care

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.


Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Ricardo Correa, M.D., Ed. D., F.A.C.E., F.A.C.P., F.A.C.M.Q: Program Director, Endocrinology, Diabetes and Metabolism Fellowship, Director for Health Equity Center at the Cleveland Clinic, Ohio, Clinical Professor of Medicine, Director for Longitudinal Didactics and Director for DEI on Mentoring of Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Health Equity Fellowship Director for Creighton School of Medicine, Phoenix 

 

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: 

Ricardo Correa, M.D., Ed. D., F.A.C.E., F.A.C.P., F.A.C.M.Q: AACE Board of Directors - Not related with educational activities or scientific activities 

The following Special Programs Committee member who planned and reviewed content for this activity reported no financial relationships:

Ismat Shafiq, MD 

The Endocrine Society member served as a special advisor and reported the following financial relationships:

Anthony Heaney, MD, PhD: Advisory Board, Speaker, Novo Nordisk, Crinetics; Advisory Board, Speakers Bureau, Recordati; Speaker (Cascade Program); Corcept; Consultant, Lundbeck 

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.


The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by an educational grant from Corcept.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By